The association between C-reactive protein to albumin ratio and 6-month neurological outcome in patients with in-hospital cardiac arrest

Ji Ho Lee, Dong Hun Lee, Byung Kook Lee, Seok Jin Ryu

Table 1. Comparisons of baseline characteristics according to neurological outcomes at 6 months

Variables Total (n=141) Favorable (n=29) Poor (n=112) P-value Demographics Age, years 68.0 (58.0-76.5) 59.2 (52.0-70.5) 70.0 (60.0-78.5) 0.003 Male, n (%) 84 (59.6) 14 (48.3) 70 (62.5) 0.238 Body mass index, kg/m2 23.3 (20.7-26.0) 23.4 (20.7-25.3) 23.1 (20.6-26.0) 0.925 Preexisting illness, n (%) Coronary artery disease 21 (14.9) 3 (10.3) 18 (16.1) 0.632 Congestive heart failure 27 (19.1) 3 (10.3) 24 (21.4) 0.277 Hypertension 84 (59.6) 17 (58.6) 67 (59.8) 1.000 Diabetes 55 (39.0) 10 (34.5) 45 (40.2) 0.729 Chronic lung disease 20 (14.2) 5 (17.2) 15 (13.4) 0.817 Renal impairment 26 (18.4) 3 (10.3) 23 (20.5) 0.321 Liver cirrhosis 4 (2.8) 0 (0.0) 4 (3.6) 0.685 Cerebrovascular accident 18 (12.8) 2 (6.9) 16 (14.3) 0.453 Malignancy 14 (9.9) 5 (17.2) 9 (8.0) 0.259 Cardiac arrest characteristics Witnessed collapse, n (%) 120 (85.1) 27 (93.1) 93 (83.0) 0.287 Shockable rhythm, n (%) 34 (24.1) 11 (37.9) 23 (20.5) 0.088 Presumed cardiac cause, n (%) 56 (39.7) 15 (51.7) 41 (36.6) 0.204 Time to ROSC, min 15.0 (7.0-23.5) 10.0 (5.0-15.0) 15.0 (10.0-29.8) 0.004 GO-FAR score 6 (-4-13) -3 (-11-3) 9 (0-13) <0.001 Clinical characteristics after ROSC Lactate, mmol/L 7.3 (4.0-12.5) 7.4 (4.6-11.8) 7.2 (3.9-13.3) 0.712 Glucose, mg/dL 204 (140-299) 236 (145-312) 203 (137-294) 0.461 PaO2, mmHg 178.0 (87.5-310.5) 274.0 (114.0-363.0) 144.0 (83.8-251.5) 0.073 PaCO2, mmHg 41.0 (29.0-58.0) 41.0 (27.5-53.1) 41.5 (29.0-58.0) 0.394 CRP, mg/dL 1.4 (0.2-8.6) 0.2 (0.0-1.2) 2.4 (0.4-10.8) <0.001 Albumin, g/dL 3.1 (2.6-3.4) 3.4 (3.0-3.8) 3.0 (2.5-3.3) <0.001 CAR 0.5 (0.1-3.0) 0.0 (0.0-0.4) 0.9 (0.1-3.5) <0.001